Chad E Groer

Title: Chad E Groer: Innovator in Pharmaceutical Chemistry

Introduction

Chad E Groer is a notable inventor based in Lawrence, KS (US), recognized for his contributions to pharmaceutical chemistry. With a total of 2 patents, Groer has made significant advancements in the field, particularly in the development of novel compounds and methods.

Latest Patents

Groer's latest patents include "Platinum(IV) conjugates and methods of use," which provides platinum(IV) compounds of Formula I or pharmaceutically acceptable salts. This patent also details compositions that include such compounds and methods for their use. Another significant patent is "Agonists of the mu opioid receptor," which focuses on non-morphinan-like mu opioid receptor agonists. These compounds demonstrate remarkable potency and selectivity for the mu opioid receptor over the kappa opioid receptor, while significantly reducing the negative side effects commonly associated with morphine-derived compounds.

Career Highlights

Throughout his career, Groer has worked with esteemed institutions such as the University of Kansas and Hylapharm, LLC. His work has contributed to the advancement of pharmaceutical research and development, particularly in pain management and cancer treatment.

Collaborations

Chad E Groer has collaborated with notable colleagues, including Thomas Edward Prisinzano and Andrew P Riley, enhancing the impact of his research through shared expertise and innovation.

Conclusion

Chad E Groer stands out as an influential inventor in the realm of pharmaceutical chemistry, with a focus on developing innovative compounds that address critical medical needs. His work continues to shape the future of drug development and therapeutic applications.